Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy.

Wolters T, Montironi R, Mazzucchelli R, Scarpelli M, Roobol MJ, van den Bergh RC, van Leeuwen PJ, Hoedemaeker RF, van Leenders GJ, Schröder FH, van der Kwast TH.

Prostate. 2012 Jan;72(1):108-15. doi: 10.1002/pros.21415. Epub 2011 May 2.

PMID:
21538424
2.
3.

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features.

Krumholtz JS, Carvalhal GF, Ramos CG, Smith DS, Thorson P, Yan Y, Humphrey PA, Roehl KA, Catalona WJ.

Urology. 2002 Sep;60(3):469-73; discussion 473-4.

PMID:
12350486
4.

Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.

Hoedemaeker RF, Rietbergen JB, Kranse R, Schröder FH, van der Kwast TH.

J Urol. 2000 Aug;164(2):411-5.

PMID:
10893598
5.

HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.

Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Scarpelli M, Lòpez Beltran A.

Hum Pathol. 2006 Sep;37(9):1137-44. Epub 2006 Jun 21.

PMID:
16938518
6.

Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view.

Elgamal AA, Van Poppel HP, Van de Voorde WM, Van Dorpe JA, Oyen RH, Baert LV.

J Urol. 1997 Jan;157(1):244-50.

PMID:
8976263
7.

Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?

Mazzucchelli R, Barbisan F, Scarpelli M, Lopez-Beltran A, van der Kwast TH, Cheng L, Montironi R.

Am J Clin Pathol. 2009 Feb;131(2):279-83. doi: 10.1309/AJCP4OCYZBAN9TJU.

PMID:
19141388
8.

Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens.

Montironi R, Mazzucchelli R, Santinelli A, Scarpelli M, Beltran AL, Bostwick DG.

Hum Pathol. 2005 Jun;36(6):646-54.

PMID:
16021571
9.

Preoperative prediction of extracapsular tumor extension at radical retropubic prostatectomy in Taiwanese patients with T1c prostate cancer.

Ou YC, Chen JT, Yang CR, Cheng CL, Ho HC, Kao YL, Ko JL, Hsieh YS.

Jpn J Clin Oncol. 2002 May;32(5):172-6.

PMID:
12110644
10.

Incidental prostate cancer detected by cystoprostatectomy in Korean men.

Joung JY, Yang SO, Seo HK, Kim TS, Han KS, Chung J, Park WS, Jeong IG, Lee KH.

Urology. 2009 Jan;73(1):153-7. doi: 10.1016/j.urology.2008.02.040. Epub 2008 Apr 14.

PMID:
18407328
11.

Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.

Freedland SJ, Sun L, Kane CJ, Presti JC Jr, Terris MK, Amling CL, Moul JW, Aronson WJ.

BJU Int. 2008 Sep;102(8):969-74. doi: 10.1111/j.1464-410X.2008.07934.x. Epub 2008 Aug 7.

13.

Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction.

Augustin H, Hammerer PG, Graefen M, Erbersdobler A, Blonski J, Palisaar J, Daghofer F, Huland H.

Eur Urol. 2003 May;43(5):455-60.

PMID:
12705986
14.
15.

Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men.

Hosseini SY, Danesh AK, Parvin M, Basiri A, Javadzadeh T, Safarinejad MR, Nahabedian A.

Int Braz J Urol. 2007 Mar-Apr;33(2):167-73; discussion 173-5.

16.

Do clinically insignificant tumors of the prostate exist?

Stamatiou K, Alevizos A, Mariolis A, Spiliopoulou C, Alevizou A, Bovis K, Sofras F.

Urol Int. 2008;81(4):379-82. doi: 10.1159/000167832. Epub 2008 Dec 10.

PMID:
19077395
17.

Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?

Soh S, Kattan MW, Berkman S, Wheeler TM, Scardino PT.

J Urol. 1997 Jun;157(6):2212-8.

PMID:
9146618
18.

A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome.

Feneley MR, Gillatt DA, Hehir M, Kirby RS.

Br J Urol. 1996 Dec;78(6):911-8; discussion 919-20.

PMID:
9014719
19.

African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.

Sanchez-Ortiz RF, Troncoso P, Babaian RJ, Lloreta J, Johnston DA, Pettaway CA.

Cancer. 2006 Jul 1;107(1):75-82.

20.

Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens.

Berger AP, Spranger R, Kofler K, Steiner H, Bartsch G, Horninger W.

Prostate. 2003 Oct 1;57(2):93-8.

PMID:
12949932

Supplemental Content

Support Center